Bridgeway Capital Management LLC Lowers Stake in Select Medical Holdings Corporation $SEM

Bridgeway Capital Management LLC cut its stake in Select Medical Holdings Corporation (NYSE:SEM) by 15.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 903,416 shares of the health services provider’s stock after selling 165,242 shares during the quarter. Bridgeway Capital Management LLC owned about 0.73% of Select Medical worth $13,714,000 at the end of the most recent quarter.

A number of other institutional investors also recently added to or reduced their stakes in the stock. Price T Rowe Associates Inc. MD grew its stake in Select Medical by 1.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 17,755,298 shares of the health services provider’s stock valued at $296,515,000 after purchasing an additional 270,488 shares during the last quarter. Vanguard Group Inc. grew its position in shares of Select Medical by 4.7% in the 1st quarter. Vanguard Group Inc. now owns 13,316,069 shares of the health services provider’s stock worth $222,378,000 after buying an additional 603,079 shares during the last quarter. State Street Corp raised its stake in shares of Select Medical by 1.3% during the 2nd quarter. State Street Corp now owns 4,253,793 shares of the health services provider’s stock worth $64,573,000 after acquiring an additional 55,686 shares in the last quarter. Geode Capital Management LLC lifted its position in Select Medical by 2.7% during the second quarter. Geode Capital Management LLC now owns 3,035,186 shares of the health services provider’s stock valued at $46,079,000 after acquiring an additional 80,425 shares during the last quarter. Finally, 8 Knots Management LLC acquired a new stake in Select Medical in the second quarter valued at approximately $26,568,000. Institutional investors own 89.48% of the company’s stock.

Analyst Upgrades and Downgrades

SEM has been the subject of several analyst reports. Bank of America decreased their price objective on Select Medical from $18.00 to $15.00 and set a “buy” rating for the company in a report on Wednesday, September 10th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Select Medical in a research note on Wednesday, October 8th. Royal Bank Of Canada boosted their price target on Select Medical from $16.00 to $20.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 8th. Mizuho set a $17.00 price objective on shares of Select Medical in a research report on Monday, November 3rd. Finally, Wall Street Zen upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. Four analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Select Medical has a consensus rating of “Moderate Buy” and a consensus price target of $17.80.

Select Medical Price Performance

Shares of NYSE SEM opened at $15.41 on Friday. Select Medical Holdings Corporation has a 52 week low of $11.65 and a 52 week high of $20.83. The business’s 50 day moving average price is $14.03 and its 200 day moving average price is $13.88. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.87. The firm has a market cap of $1.91 billion, a P/E ratio of 17.91, a P/E/G ratio of 0.57 and a beta of 1.28.

Select Medical (NYSE:SEM) last announced its quarterly earnings data on Thursday, October 30th. The health services provider reported $0.23 EPS for the quarter, beating the consensus estimate of $0.18 by $0.05. The business had revenue of $1.36 billion during the quarter, compared to analysts’ expectations of $1.33 billion. Select Medical had a net margin of 2.05% and a return on equity of 7.41%. The business’s quarterly revenue was up 7.2% compared to the same quarter last year. During the same period in the previous year, the business posted $0.43 EPS. Select Medical has set its FY 2025 guidance at 1.140-1.240 EPS. On average, sell-side analysts expect that Select Medical Holdings Corporation will post 1.17 earnings per share for the current year.

Select Medical Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, November 25th. Shareholders of record on Wednesday, November 12th were issued a $0.0625 dividend. This represents a $0.25 annualized dividend and a yield of 1.6%. The ex-dividend date of this dividend was Wednesday, November 12th. Select Medical’s dividend payout ratio is presently 29.07%.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.